title: [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].
authors.affiliation: Dept of Internal Medicine, National Hospital Organization Shikoku Cancer Center.
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Moriwaki
authors.forename: Ichinosuke
authors.initials: I
authors.lastname: Hyodo
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Nishina
authors.forename: Junichirou
authors.initials: J
authors.lastname: Nasu
authors.forename: Satoru
authors.initials: S
authors.lastname: Hidaka
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kajiwara
authors.forename: Takao
authors.initials: T
authors.lastname: Tsuzuki
authors.forename: Ken
authors.initials: K
authors.lastname: Hirao
authors.forename: Eiji
authors.initials: E
authors.lastname: Tsubouchi
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Yamauchi
authors.forename: Shoji
authors.initials: S
authors.lastname: Hirasaki
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Masumoto
authors.forename: Minoru
authors.initials: M
authors.lastname: Tanada
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine